Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on October 2, 2025
October 2, 2025
Newsmatics Turns 30: Online News Pioneer Launches Giveaway to Celebrate Three Decades of Innovation
Indeterminate
EIN Presswire
October 2, 2025
India Embraces a New Age of Digital Connectivity through Sama X
Indeterminate
EIN Presswire
October 2, 2025
DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
Indeterminate
EIN Presswire
October 2, 2025
Jolt Capital invests in P2i specialist in water-repellent nano-coating solutions
Indeterminate
EIN Presswire
October 2, 2025
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
Indeterminate
GlobeNewswire
October 2, 2025
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Quantum Artificial Intelligence Synthetic Data Generator Market to Reach $9.66 Billion by 2029 with 36.3% CAGR
Indeterminate
EIN Presswire
October 2, 2025
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 2, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
Indeterminate
GlobeNewswire
October 2, 2025
Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
Indeterminate
GlobeNewswire
October 2, 2025
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
Indeterminate
GlobeNewswire
October 2, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Indeterminate
GlobeNewswire
October 2, 2025
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
Indeterminate
GlobeNewswire